Abstract
ABSTRACT: Twenty-four growth hormone-deficient children were treated with growth hormone releasing hormone-40 (GHRH) for 6 months or longer. GHRH (1 to 4 μg/kg of body weight per dose) was administered subcutaneously every 3 h (n = 10); or every 3 h overnight only (n = 10); or by twice daily injections (n = 4). Twenty-one children had an increase in growth rate during GHRH treatment. The growth velocities (mean ± SD; cm/yr) before and during treatment were, respectively: every 3 h 3.5 ± 1.4 versus 10.0 ± 2.2, p = 0.0001; overnight only 3.4 ± 1.0 versus 6.2 ± 2.1, p = 0.008; twice daily injections 3.2 ± 1.8 versus 7.9 ± 2.4, p = 0.06. Using these three modes of GHRH administration, different total daily amounts of GHRH were administered. Regression analysis of average daily dose versus growth velocity revealed a correlation coefficient (r) value of 0.57, p = 0.004. Sixteen children received extended treatment for periods varying from 9 to 30 months. Of these, seven children were treated continuously for 9 months with pump overnight only and 5 for 12 months with pump every 3 h. Their growth velocities were sustained at a similar rate as those observed at 6 months. Six children received both twice daily and three hourly treatments consecutively. The growth velocities were similar during both treatments. Eleven children developed circulating antibodies to GHRH during treatment, however, all 11 had accelerated growth rates during GHRH therapy. GHRH can stimulate growth hormone secretion and its biologic effects to accelerate linear growth in children with growth hormone deficiency. Further studies are required to characterize the optimal dose and frequency of administration.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thorner, M., Rogol, A., Blizzard, R. et al. Acceleration of Growth Rate in Growth Hormone-Deficient Children Treated with Human Growth Hormone-Releasing Hormone. Pediatr Res 24, 145–151 (1988). https://doi.org/10.1203/00006450-198808000-00001
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-198808000-00001
This article is cited by
-
Potential applications of GH secretagogs in the evaluation and treatment of the age-related decline in growth hormone secretion
Endocrine (1997)
-
A little lesson in growth regulation
Nature Genetics (1996)
-
Long term growth hormone (GH)-releasing hormone and biosynthetic GH therapy in GH-deficient children: comparison of therapeutic effectiveness
Journal of Endocrinological Investigation (1990)